A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 397 shares of DGX stock, worth $54,424. This represents 0.0% of its overall portfolio holdings.

Number of Shares
397
Holding current value
$54,424
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$137.09 - $137.09 $54,424 - $54,424
397 New
397 $54,000
Q1 2023

May 11, 2023

BUY
$131.53 - $155.76 $109,301 - $129,436
831 Added 85.49%
1,803 $255,000
Q4 2022

Jan 24, 2023

BUY
$123.31 - $157.26 $246 - $314
2 Added 0.21%
972 $152,000
Q3 2022

Nov 04, 2022

SELL
$121.77 - $141.1 $41,888 - $48,538
-344 Reduced 26.18%
970 $119,000
Q2 2022

Jul 22, 2022

BUY
$127.07 - $145.39 $2,414 - $2,762
19 Added 1.47%
1,314 $175,000
Q1 2022

May 09, 2022

BUY
$129.09 - $164.35 $3,098 - $3,944
24 Added 1.89%
1,295 $177,000
Q4 2021

Feb 15, 2022

BUY
$140.36 - $173.01 $7,579 - $9,342
54 Added 4.44%
1,271 $220,000
Q3 2021

Nov 12, 2021

SELL
$132.95 - $158.0 $200,887 - $238,738
-1,511 Reduced 55.39%
1,217 $177,000
Q2 2021

Jul 23, 2021

SELL
$126.66 - $141.48 $33,311 - $37,209
-263 Reduced 8.79%
2,728 $360,000
Q1 2021

May 10, 2021

BUY
$114.63 - $133.34 $101,447 - $118,005
885 Added 42.02%
2,991 $384,000
Q4 2020

Feb 24, 2021

SELL
$112.7 - $128.05 $3.89 Million - $4.42 Million
-34,479 Reduced 94.24%
2,106 $251,000
Q4 2020

Feb 12, 2021

BUY
$112.7 - $128.05 $4.09 Million - $4.65 Million
36,312 Added 13301.1%
36,585 $251,000
Q3 2020

Nov 10, 2020

SELL
$107.05 - $130.01 $156,721 - $190,334
-1,464 Reduced 84.28%
273 $31,000
Q1 2020

May 13, 2020

BUY
$75.14 - $115.68 $130,518 - $200,936
1,737 New
1,737 $139,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Bank Julius Baer & Co. Ltd, Zurich Portfolio

Follow Bank Julius Baer & Co. Ltd, Zurich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.